(VIANEWS) - BRT Realty Trust (BRT), Powell Industries (POWL), LHC Group (LHCG) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. BRT Realty Trust (BRT)
103.6% sales growth and 22.9% return on equity
BRT, a real-estate investment trust, is responsible for the development and ownership of multifamily properties.
Earnings per Share
BRT Realty Trust's trailing 12 month EPS is $2.81.
PE Ratio
BRT Realty Trust's trailing 12-month price-to-earnings ratio is 6.95. The purchaser of the shares is investing $6.95 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 22.9%.Moving Average
BRT Realty Trust's value is under its 50-day moving average of $20.72 and way under its 200-day moving average of $21.98.Volume
Today's last reported volume for BRT Realty Trust is 53115 which is 16.4% below its average volume of 63542.
Revenue Growth
Year-on-year quarterly revenue growth declined by 13.5%, now sitting on 95.39M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
BRT Realty Trust's EBITDA is 13.96.
2. Powell Industries (POWL)
9.5% sales growth and 4.59% return on equity
Powell Industries, Inc., along with its subsidiaries, design, develop, manufacture, sells, services, and supports custom-engineered equipment for distribution, control, monitoring, and monitoring electrical energy. Its main products are integrated power control rooms substations, customized modules, electric houses, medium voltage circuit breakers and monitoring and control communication systems. Bus duct systems and traditional as well as arc-resistant distribution switchesgears. The company's products are suitable for voltages from 480 to 38,000 Volts. They can be used in onshore and offshore oil & gas production, oil and natural gas refining and terminal, mining, metals, light rail power, electric utility and pulp and paper. The company also offers value-added service, including spare parts, field inspection, modification, repair, retrofit, retrofill, retrofit, and modification of existing systems and replacement switchgear circuit breakers. It has offices in America, Canada, Mexico, Central and South America, Canada, Middle East, Africa and Europe. Powell Industries, Inc., was established in Houston, Texas in 1947.
Earnings per Share
Powell Industries' trailing 12 month EPS is $1.15.
PE Ratio
Powell Industries' trailing 12 months earnings to price ratio is 29.86. The purchaser of the shares is therefore investing $29.86 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is an indicator of the business' profitability relative to shareholders' equity, was 4.59%.Yearly Top and Bottom Value
Powell Industries's stock is valued at $34.34 at 10:22 EST, below its 52-week high of $38.14 and way above its 52-week low of $18.81.
Average Moving
Powell Industries is worth more than its moving average for 50 days of $29.03, and much higher than that of its moving average for 200 days of $24.76.Revenue growth
Annual revenue growth was 25.7% year-on-year, and now stands at 532.58M in the 12 trailing months.
3. LHC Group (LHCG)
6.9% sales growth and 5.64% return on equity
LHC Group, Inc. is a provider of health care services that focuses on the post-acute continuum care for Medicare beneficiaries. Home Health Services is the company's segment. It offers nursing services such as wound care, dressing changes, heart rehabilitation, infusion therapy and pain management. The Hospice Services segment offers pain management, including emotional and spiritual support as well as inpatient respite and homemaker care. It also provides dietary counseling and family bereavement counselling. Home and Community-Based Services offers a range of services including assistance in grooming, medication reminders and meal preparation. It also provides light housekeeping and transportation services for patients at home and in medical facilities. The company's Facility-Based Services segment provides care for patients with respiratory problems, cardiac and neuromuscular disorders, chronic pain, kidney disorders, cancers, and head and neck injury. It also treats patients who have musculoskeletal impairments. Healthcare Innovations (HCI), the company's services segment, provides strategic healthcare management to accountable care organisations. It had 537 locations for home care, 120 hospices, 124 service-based locations, 11 long term acute hospitals, 12 location HCI locations and 11 community-based locations. Lafayette is the home of the company, which was established in 1994.
Earnings per Share
LHC Group's trailing twelve-month EPS is $3.56.
PE Ratio
LHC Group's trailing 12-month price-earnings ratio is 45.42. The purchaser of the shares is therefore investing $45.42 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is an indicator of the business' profitability relative to shareholders' equity, was 5.64%.4. West Pharmaceutical (WST)
5.8% sales growth and 30.76% return on equity
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Earnings per Share
West Pharmaceutical's trailing 12 month EPS is $5.57.
PE Ratio
West Pharmaceutical's trailing 12 months earnings to price ratio is 42.72. The purchaser of the shares is therefore investing $42.72 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 30.76%.Sales Growth
West Pharmaceutical's sales growth is 5.5% for the current quarter and 5.8% for the next.